Executive Summary
Trading comparables analysis for Smith & Nephew benchmarking valuation multiples against relevant medical device peers. Built from public filings.
Objective
To establish a relative valuation framework contextualising Smith & Nephew's market valuation against comparable medical device companies.
Approach
- —Identified relevant peer group based on business model and market positioning
- —Compiled trading multiples across EV/Revenue, EV/EBITDA, and P/E
- —Analysed drivers of multiple differences
- —Assessed implied valuation range
Key Outputs
- —Trading comparables analysis with peer benchmarking
- —Multiple comparison and driver analysis
- —Implied valuation range assessment
Commercial Insight
Relative valuation requires careful peer selection and understanding of why multiples differ. Premium multiples are typically justified by superior growth, margins, or capital efficiency.
Tools & Methods
ExcelAnnual ReportsMarket Data
Next Project
National Grid – Precedent Transactions→